| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Director | Common Stock | 104K | $1.04K | $0.01 | Feb 18, 2025 | Direct |
| Traws Pharma, Inc. | Director | Series A Warrant (right to buy) | 96.3K | Dec 29, 2024 | Direct | ||
| Traws Pharma, Inc. | Director | Stock Option (right to purchase) | 11.5K | Oct 12, 2025 | Direct | ||
| Traws Pharma, Inc. | Director | Pre-Funded Warrant (right to buy) | 0 | Feb 18, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | Oct 12, 2025 | 1 | $0 | 4 | Oct 15, 2025 | Director |
| TRAW | Traws Pharma, Inc. | Jun 19, 2025 | 1 | $0 | 4 | Jun 23, 2025 | Director |
| TRAW | Traws Pharma, Inc. | Feb 18, 2025 | 2 | $963 | 4 | Feb 19, 2025 | Chief Executive Officer, Director |
| TRAW | Traws Pharma, Inc. | Dec 29, 2024 | 2 | $0 | 4 | Jan 27, 2025 | Chief Executive Officer, Director |
| TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Chief Executive Officer, Director |
| TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Chief Executive Officer, Director |